Tyler Andrew R, Mosaei Hamed, Morton Stephanie, Waddell Paul G, Wills Corinne, McFarlane William, Gray Joe, Goodfellow Michael, Errington Jeff, Allenby Nick, Zenkin Nikolay, Hall Michael J
Demuris Limited, Newcastle Biomedicine Bio-Incubators , Framlington Place, Newcastle upon Tyne, NE2 4HH, U.K.
J Nat Prod. 2017 May 26;80(5):1558-1562. doi: 10.1021/acs.jnatprod.7b00082. Epub 2017 Apr 11.
The madurastatins are pentapeptide siderophores originally described as containing an unusual salicylate-capped N-terminal aziridine ring. Isolation of madurastatin C1 (1) (also designated MBJ-0034), from Actinomadura sp. DEM31376 (itself isolated from a deep sea sediment), prompted structural reevaluation of the madurastatin siderophores, in line with the recent work of Thorson and Shaaban. NMR spectroscopy in combination with partial synthesis allowed confirmation of the structure of madurastatin C1 (1) as containing an N-terminal 2-(2-hydroxyphenyl)oxazoline in place of the originally postulated aziridine, while absolute stereochemistry was determined via Harada's advanced Marfey's method. Therefore, this work further supports Thorson and Shaaban's proposed structural revision of the madurastatin class of siderophores (madurastatins A1 (2), B1 (3), C1 (1), and MBJ-0036 (4)) as N-terminal 2-(2-hydroxyphenyl)oxazolines.
马杜拉他汀是一种五肽铁载体,最初被描述为含有一个不寻常的水杨酸酯封端的N-末端氮杂环丙烷环。从马杜拉放线菌属DEM31376(其本身是从深海沉积物中分离出来的)中分离出马杜拉他汀C1(1)(也称为MBJ-0034),促使对马杜拉他汀铁载体进行结构重新评估,这与索尔森和沙班最近的工作一致。核磁共振光谱结合部分合成,证实了马杜拉他汀C1(1)的结构,其含有一个N-末端2-(2-羟基苯基)恶唑啉,取代了最初假定的氮杂环丙烷,而绝对立体化学是通过原田改进的马尔菲法确定的。因此,这项工作进一步支持了索尔森和沙班提出的将马杜拉他汀类铁载体(马杜拉他汀A1(2)、B1(3)、C1(1)和MBJ-0036(4))的结构修订为N-末端2-(2-羟基苯基)恶唑啉的提议。